{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T04:50:13Z","timestamp":1785387013196,"version":"3.55.0"},"reference-count":87,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2015,9,23]],"date-time":"2015-09-23T00:00:00Z","timestamp":1442966400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0138895","type":"journal-article","created":{"date-parts":[[2015,9,23]],"date-time":"2015-09-23T18:19:03Z","timestamp":1443032343000},"page":"e0138895","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":15,"title":["No Outbreak of Vancomycin and Linezolid Resistance in Staphylococcal Pneumonia over a 10-Year Period"],"prefix":"10.1371","volume":"10","author":[{"given":"Josef","family":"Yayan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beniam","family":"Ghebremedhin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kurt","family":"Rasche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2015,9,23]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"8753","DOI":"10.3390\/ijms15058753","article-title":"Colonization and infection of the skin by S. aureus: immune system evasion and the response to cationic antimicrobial peptides","volume":"15","author":"S Ryu","year":"2014","journal-title":"Int J Mol Sci"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1038\/nrmicro2537","article-title":"The skin microbiome","volume":"9","author":"EA Grice","year":"2011","journal-title":"Nat Rev Microbiol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"3568","DOI":"10.1128\/AAC.00851-07","article-title":"Health care-associated pneumonia and community-acquired pneumonia: a single-center experience","volume":"51","author":"ST Micek","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1136\/pmj.77.905.148","article-title":"Use of the diagnostic bacteriology laboratory: a practical review for the clinician","volume":"77","author":"WJ Steinbach","year":"2001","journal-title":"Postgrad Med J"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.jcis.2008.11.025","article-title":"Mobile and immobile adhesion of staphylococcal strains to hydrophilic and hydrophobic surfaces","volume":"331","author":"NP Boks","year":"2009","journal-title":"J Colloid Interface Sci"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1111\/j.1365-2672.2012.05338.x","article-title":"Natural antimicrobial peptides from bacteria: characteristics and potential applications to fight against antibiotic resistance","volume":"113","author":"M Hassan","year":"2012","journal-title":"J Appl Microbiol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1128\/CMR.00037-09","article-title":"Three decades of beta-lactamase inhibitors","volume":"23","author":"SM Drawz","year":"2010","journal-title":"Clin Microbiol Rev"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1086\/593120","article-title":"Screening for MRSA: a flawed hospital infection control intervention","volume":"29","author":"RP Wenzel","year":"2008","journal-title":"Infect Control Hosp Epidemiol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1097\/01.CCM.0000201405.16525.34","article-title":"Antimicrobial resistance in nosocomial bloodstream infection associated with pneumonia and the value of systematic surveillance cultures in an adult intensive care unit","volume":"34","author":"PO Depuydt","year":"2006","journal-title":"Crit Care Med"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.ijmm.2007.10.005","article-title":"Emergence and spread of antibiotic-resistant Gram-positive bacterial pathogens","volume":"298","author":"W Witte","year":"2008","journal-title":"Int J Med Microbiol"},{"issue":"3 Suppl","key":"ref11","doi-asserted-by":"crossref","first-page":"S89","DOI":"10.1016\/j.jamda.2005.12.021","article-title":"Preventing antimicrobial-resistant bacterial infections among older adults in long-term care facilities","volume":"7","author":"CL Richards Jr","year":"2006","journal-title":"J Am Med Dir Assoc"},{"issue":"Suppl 1","key":"ref12","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/S0924-8579(00)00299-5","article-title":"Antibiotic resistance in staphylococci","volume":"16","author":"DM Livermore","year":"2000","journal-title":"Int J Antimicrob Agents"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1186\/2047-783X-15-12-507","article-title":"Nosocomial methicillin-resistant Staphylococcus aureus (MRSA) pneumonia: linezolid or vancomycin?\u2014Comparison of pharmacology and clinical efficacy","volume":"15","author":"MW Pletz","year":"2010","journal-title":"Eur J Med Res"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1093\/jac\/dks354","article-title":"The emerging problem of linezolid-resistant Staphylococcus","volume":"68","author":"B Gu","year":"2013","journal-title":"J Antimicrob Chemother"},{"key":"ref15","unstructured":"World Health Organization (WHO). International Classification of Diseases (ICD). Available: http:\/\/www.who.int\/classification\/icd\/en\/<\/ext-link>. Accessed 6 June 2015."},{"key":"ref16","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1159\/000087452","article-title":"Current guidelines for the treatment of severe pneumonia and sepsis","volume":"51","author":"KF Bodmann","year":"2005","journal-title":"Chemotherapy"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1164\/ajrccm.163.7.at1010","article-title":"Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention","volume":"163","author":"MS Niederman","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"ref18","first-page":"1299","article-title":"Diagnosis and management of community-acquired pneumonia in adults","volume":"83","author":"RR Watkins","year":"2011","journal-title":"Am Fam Physician"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0272-5231(21)00471-8","article-title":"Diagnosis of bacterial infections of the lung","volume":"8","author":"JG Barlett","year":"1987","journal-title":"Clin Chest Med"},{"key":"ref20","unstructured":"Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. CLSI M100-S22. Wayne, Pa: Clinical and Laboratory Standards Institute; 2012."},{"key":"ref21","unstructured":"European Committee on Antimicrobial Susceptibility Testing (EUCAST) breakpoints 2011\u20132014. Available: http:\/\/www.eucast.org<\/ext-link>. Accessed 6 June 2015."},{"key":"ref22","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1093\/ajcp\/45.4_ts.493","article-title":"Antibiotic susceptibility testing by a standardized single disk method","volume":"45","author":"AW Bauer","year":"1966","journal-title":"Am J Clin Pathol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"e000091","DOI":"10.1136\/bmjresp-2015-000091","article-title":"British Thoracic Society community acquired pneumonia guideline and the NICE pneumonia guideline: how they fit together","volume":"2","author":"WS Lim","year":"2015","journal-title":"BMJ Open Respir Res"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1128\/CMR.00081-09","article-title":"Community-associated methicillin-resistant Staphylococcus aureus: epidemiology and clinical consequences of an emerging epidemic","volume":"23","author":"MZ David","year":"2010","journal-title":"Clin Microbiol Rev"},{"key":"ref25","first-page":"81","article-title":"Staphylococcus aureus outbreak in the intensive care unit of the largest public hospital in Quito, Ecuador","volume":"16","author":"PA Cardenas","year":"2013","journal-title":"Int Microbiol"},{"issue":"Suppl 5","key":"ref26","doi-asserted-by":"crossref","first-page":"S378","DOI":"10.1086\/533594","article-title":"Pneumonia caused by methicillin-resistant Staphylococcus aureus","volume":"46","author":"E Rubinstein","year":"2008","journal-title":"Clin Infect Dis"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1159\/000339989","article-title":"Complications of oropharyngeal dysphagia: aspiration pneumonia","volume":"72","author":"J Almirall","year":"2012","journal-title":"Nestle Nutr Inst Workshop Ser"},{"issue":"6 Suppl","key":"ref28","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1177\/014860710202600604","article-title":"Aspiration pneumonia: incidence, mortality, and at-risk populations","volume":"26","author":"MH DeLegge","year":"2002","journal-title":"JPEN J Parenter Enteral Nutr"},{"issue":"4","key":"ref29","first-page":"897","article-title":"Epidemiology, clinical characteristics and treatment outcomes of healthcare-associated methicillin-resistant Staphylococcus aureus BLOODSTREAM infections at Chiang Mai University Hospital: a retrospective study","volume":"45","author":"R Chaiwarith","year":"2014","journal-title":"Southeast Asian J Trop Med Public Health"},{"key":"ref30","unstructured":"Reith K. Der Kampf gegen gef\u00e4hrliche Keime im Krankenhaus. Westdeutsche Zeitung. 2015. [in German]. Available: http:\/\/www.wz-newsline.de\/lokales\/wuppertal\/der-kampf-gegen-gefaehrliche-keime-im-krankenhaus-1.1836784<\/ext-link>. Accessed 29 August 2015."},{"issue":"Suppl 1","key":"ref31","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1086\/491709","article-title":"Vancomycin: a history","volume":"42","author":"DP Levine","year":"2006","journal-title":"Clin Infect Dis"},{"issue":"Suppl 1","key":"ref32","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1086\/491711","article-title":"Vancomycin resistance in Gram-positive cocci","volume":"42","author":"P Courvalin","year":"2006","journal-title":"Clin Infect Dis"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.cll.2004.03.004","article-title":"Vancomycin resistance in Staphylococcus aureus","volume":"24","author":"PC Appelbaum","year":"2004","journal-title":"Clin Lab Med"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1089\/mdr.2011.0014","article-title":"Prevalence of vanC vancomycin-resistant enterococci in the teaching hospitals of the University of Debrecen, Hungary","volume":"18","author":"Z Dombr\u00e1di","year":"2012","journal-title":"Microb Drug Resist"},{"issue":"Suppl 3","key":"ref35","doi-asserted-by":"crossref","first-page":"S184","DOI":"10.1086\/519471","article-title":"Alternatives to vancomycin for the treatment of methicillin-resistant Staphylococcus aureus infections","volume":"45","author":"ST Micek","year":"2007","journal-title":"Clin Infect Dis"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1086\/318486","article-title":"Linezolid Nosocomial Pneumonia Study Group. Linezolid (PNU-100766) versus vancomycin in the treatment of hospitalized patients with nosocomial pneumonia: a randomized, double-blind, multicenter study","volume":"32","author":"E Rubinstein","year":"2001","journal-title":"Clin Infect Dis"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1097\/CCM.0b013e3181eb3b96","article-title":"Linezolid versus vancomycin or teicoplanin for nosocomial pneumonia: a systematic review and meta-analysis","volume":"38","author":"AC Kalil","year":"2010","journal-title":"Crit Care Med"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1378\/chest.10-1556","article-title":"Linezolid vs glycopeptide antibiotics for the treatment of suspected methicillin-resistant Staphylococcus aureus nosocomial pneumonia: a meta-analysis of randomized controlled trials","volume":"139","author":"AJ Walkey","year":"2011","journal-title":"Chest"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s00228-014-1775-x","article-title":"Linezolid versus vancomycin for the treatment of suspected methicillin-resistant Staphylococcus aureus nosocomial pneumonia: a systematic review employing meta-analysis","volume":"71","author":"Y Wang","year":"2015","journal-title":"Eur J Clin Pharmacol"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1345\/aph.1R370","article-title":"Pharmacotherapy for methicillin-resistant Staphylococcus aureus nosocomial pneumonia","volume":"46","author":"M Segarra-Newnham","year":"2012","journal-title":"Ann Pharmacother"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"e003912","DOI":"10.1136\/bmjopen-2013-003912","article-title":"Treatment of hospital-acquired pneumonia with linezolid or vancomycin: a systematic review and meta-analysis","volume":"3","author":"AC Kalil","year":"2013","journal-title":"BMJ Open"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.ijantimicag.2010.06.045","article-title":"Antimicrobial treatment of nosocomial methicillin-resistant Staphylococcus aureus (MRSA) pneumonia: current and future options","volume":"36","author":"T Welte","year":"2010","journal-title":"Int J Antimicrob Agents"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/j.bcp.2005.12.005","article-title":"Glycopeptides: update on an old successful antibiotic class","volume":"71","author":"JL Pace","year":"2006","journal-title":"Biochem Pharmacol"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1128\/CMR.3.3.280","article-title":"Resistance to vancomycin and teicoplanin: an emerging clinical problem","volume":"3","author":"AP Johnson","year":"1990","journal-title":"Clin Microbiol Rev"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1097\/MCC.0000000000000124","article-title":"Risks for multidrug-resistant pathogens in the ICU","volume":"20","author":"I Mart\u00edn-Loeches","year":"2014","journal-title":"Curr Opin Crit Care"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1093\/jac\/47.2.239","article-title":"Fluit AC; European SENTRY Participants. Resistance to tetracycline and distribution of tetracycline resistance genes in European Staphylococcus aureus isolates","volume":"47","author":"FJ Schmitz","year":"2001","journal-title":"J Antimicrob Chemother"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1093\/jac\/45.6.763","article-title":"Expression of resistance to tetracyclines in strains of methicillin-resistant Staphylococcus aureus","volume":"45","author":"K Trzcinski","year":"2000","journal-title":"J Antimicrob Chemother"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1097\/CCM.0b013e3181b9ecea","article-title":"Effect of vancomycin plus rifampicin in the treatment of nosocomial methicillin-resistant Staphylococcus aureus pneumonia","volume":"38","author":"YJ Jung","year":"2010","journal-title":"Crit Care Med"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1517\/14656566.2011.599320","article-title":"Current review of antimicrobial treatment of nosocomial pneumonia caused by multidrug-resistant pathogens","volume":"12","author":"SS Jean","year":"2011","journal-title":"Expert Opin Pharmacother"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1345\/aph.1R726","article-title":"Addition of rifampin to vancomycin for methicillin-resistant Staphylococcus aureus infections: what is the evidence?","volume":"47","author":"S Tremblay","year":"2013","journal-title":"Ann Pharmacother"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1097\/CCM.0b013e3181db7d28","article-title":"Vancomycin plus rifampicin for methicillin-resistant Staphylococcus aureus pneumonia benefits only those who have no development of rifampicin resistance during treatment","volume":"38","author":"CK Tan","year":"2010","journal-title":"Crit Care Med"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1093\/jac\/dkq179","article-title":"Co-trimoxazole versus vancomycin for the treatment of methicillin-resistant Staphylococcus aureus bacteraemia: a retrospective cohort study","volume":"65","author":"E Goldberg","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"390","DOI":"10.7326\/0003-4819-117-5-390","article-title":"Trimethoprim-sulfamethoxazole compared with vancomycin for the treatment of Staphylococcus aureus infection","volume":"117","author":"N Markowitz","year":"1992","journal-title":"Ann Intern Med"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1517\/13543780902967624","article-title":"Fosfomycin for the treatment of infections caused by Gram-positive cocci with advanced antimicrobial drug resistance: a review of microbiological, animal and clinical studies","volume":"18","author":"ME Falagas","year":"2009","journal-title":"Expert Opin Investig Drugs"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1093\/jac\/48.2.209","article-title":"In vitro activity of fosfomycin in combination with various antistaphylococcal substances","volume":"48","author":"K Grif","year":"2001","journal-title":"J Antimicrob Chemother"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.jfma.2013.10.002","article-title":"Update on new medicinal applications of gentamicin: evidence-based review","volume":"113","author":"C Chen","year":"2014","journal-title":"J Formos Med Assoc"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1007\/s00134-002-1223-8","article-title":"Eradication of endotracheal tube biofilm by nebulised gentamicin","volume":"28","author":"CG Adair","year":"2002","journal-title":"Intensive Care Med"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1017\/S0195941700061737","article-title":"A comparison of pneumonia caused by gentamicin, methicillin-resistant and gentamicin, methicillin-sensitive Staphylococcus aureus: epidemiologic and clinical studies","volume":"6","author":"JR Lentino","year":"1985","journal-title":"Infect Control"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.jinf.2012.06.009","article-title":"Antimicrobial resistance and molecular typing of Staphylococcus aureus bloodstream isolates from hospitals in Peru","volume":"65","author":"C Garc\u00eda","year":"2012","journal-title":"J Infect"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1128\/AAC.39.8.1764","article-title":"Bactericidal killing activities of cefepime, ceftazidime, cefotaxime, and ceftriaxone against Staphylococcus aureus and beta-lactamase-producing strains of Enterobacter aerogenes and Klebsiella pneumoniae in an in vitro infection model","volume":"39","author":"SM Palmer","year":"1995","journal-title":"Antimicrob Agents Chemother"},{"key":"ref61","first-page":"841","article-title":"In vitro bactericidal activity of cefepime and cefpirome against clinical isolates at Karachi","volume":"28","author":"A Arsalan","year":"2015","journal-title":"Pak J Pharm Sci"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1002\/jbm.b.33117","article-title":"Biomechanical and antibacterial properties of Tobramycin loaded hydroxyapatite coated fixation pins","volume":"102","author":"JH S\u00f6rensen","year":"2014","journal-title":"J Biomed Mater Res B Appl Biomater"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1089\/mdr.2014.0139","article-title":"Antimicrobial resistance and molecular analysis of methicillin-resistant Staphylococcus aureus collected in a Spanish hospital","volume":"21","author":"M Hern\u00e1ndez-Porto","year":"2015","journal-title":"Microb Drug Resist"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1513\/AnnalsATS.201311-395FR","article-title":"Inhaled antibiotics for lower airway infections","volume":"11","author":"BS Quon","year":"2014","journal-title":"Ann Am Thorac Soc"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0732-8893(01)00262-0","article-title":"Correlation of MIC methods and tentative interpretive criteria for disk diffusion susceptibility testing using NCCLS methodology for fusidic acid","volume":"40","author":"R Skov","year":"2001","journal-title":"Diagn Microbiol Infect Dis"},{"key":"ref66","first-page":"254","article-title":"The impact of antibiotic use on hospital-acquired pneumonia: data of etiology tests","volume":"39","author":"A Vitkauskiene","year":"2003","journal-title":"Medicina (Kaunas)"},{"key":"ref67","doi-asserted-by":"crossref","first-page":"4985","DOI":"10.1128\/AAC.00523-10","article-title":"Fusidic acid resistance determinants in Staphylococcus aureus clinical isolates","volume":"54","author":"HJ Chen","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"issue":"Suppl 2","key":"ref68","doi-asserted-by":"crossref","first-page":"14","DOI":"10.2165\/00003495-198800352-00006","article-title":"In vitro activity of cefotaxime against clinically significant pathogens","volume":"35","author":"S Nakashio","year":"1988","journal-title":"Drugs"},{"key":"ref69","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/AAC.18.1.1","article-title":"In vitro antimicrobial activity of cefotaxime, a new cephalosporin","volume":"18","author":"S Masuyoshi","year":"1980","journal-title":"Antimicrob Agents Chemother"},{"issue":"Suppl","key":"ref70","doi-asserted-by":"crossref","first-page":"S300","DOI":"10.1093\/clinids\/4.Supplement_2.S300","article-title":"Cefotaxime: a review of in vitro antimicrobial properties and spectrum of activity","volume":"4","author":"RN Jones","year":"1982","journal-title":"Rev Infect Dis"},{"key":"ref71","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1159\/000069779","article-title":"Comparison of the bactericidal activity of moxifloxacin and levofloxacin against Staphylococcus aureus, Staphylococcus epidermidis, Escherichia coli and Klebsiella pneumoniae","volume":"49","author":"SW Lemmen","year":"2003","journal-title":"Chemotherapy"},{"key":"ref72","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.ijantimicag.2008.07.017","article-title":"Susceptibility patterns of bacterial isolates from hospitalised patients with respiratory tract infections (MOXIAKTIV Study)","volume":"33","author":"E Jacobs","year":"2009","journal-title":"Int J Antimicrob Agents"},{"key":"ref73","doi-asserted-by":"crossref","first-page":"3437","DOI":"10.1128\/AAC.00317-09","article-title":"Inoculum effect with cefazolin among clinical isolates of methicillin-susceptible Staphylococcus aureus: frequency and possible cause of cefazolin treatment failure","volume":"53","author":"EC Nannini","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"ref74","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1089\/mdr.2013.0229","article-title":"Clinical implications of cefazolin inoculum effect and \u03b2-lactamase type on methicillin-susceptible Staphylococcus aureus bacteremia","volume":"20","author":"S Lee","year":"2014","journal-title":"Microb Drug Resist"},{"key":"ref75","first-page":"37","article-title":"The rate of inducible clindamycin resistance and susceptibilities to other antimicrobial agents in staphylococci","volume":"43","author":"VA O\u011fuz","year":"2009","journal-title":"Mikrobiyol Bul"},{"key":"ref76","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.1093\/jac\/dkt254","article-title":"Cefazolin high-inoculum effect in methicillin-susceptible Staphylococcus aureus from South American hospitals","volume":"68","author":"S Rinc\u00f3n","year":"2013","journal-title":"J Antimicrob Chemother"},{"key":"ref77","first-page":"113","article-title":"Antimicrobial susceptibility of community-acquired respiratory tract pathogens isolated from adults in China during 2009 and 2010","volume":"35","author":"H Wang","year":"2012","journal-title":"Zhonghua Jie He He Hu Xi Za Zhi"},{"key":"ref78","first-page":"27","article-title":"Microbiological evaluation of differences between cephalosporins of second and third generations in general hospital","volume":"48","author":"MB Bogdanov","year":"2003","journal-title":"Antibiot Khimioter"},{"key":"ref79","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1086\/426894","article-title":"Inducible clindamycin resistance in Staphylococci: should clinicians and microbiologists be concerned?","volume":"40","author":"JS Lewis 2nd","year":"2005","journal-title":"Clin Infect Dis"},{"key":"ref80","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2165\/00003495-200262010-00002","article-title":"A critical review of the fluoroquinolones: focus on respiratory infections","volume":"62","author":"GG Zhanel","year":"2002","journal-title":"Drugs"},{"key":"ref81","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1001\/archinte.1990.00390210111024","article-title":"Emergence of ciprofloxacin resistance in nosocomial methicillin-resistant Staphylococcus aureus isolates. Resistance during ciprofloxacin plus rifampin therapy for methicillin-resistant S aureus colonization","volume":"150","author":"LR Peterson","year":"1990","journal-title":"Arch Intern Med"},{"key":"ref82","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.pneumo.2013.08.004","article-title":"Staphylococcus aureus broncho-pulmonary infections","volume":"69","author":"F Valour","year":"2013","journal-title":"Rev Pneumol Clin"},{"key":"ref83","doi-asserted-by":"crossref","first-page":"12478","DOI":"10.3390\/molecules171112478","article-title":"Development of new drugs for an old target: the penicillin binding proteins","volume":"17","author":"A Zervosen","year":"2012","journal-title":"Molecules"},{"key":"ref84","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1021\/cb2001846","article-title":"Structure-guided design of cell wall biosynthesis inhibitors that overcome \u03b2-lactam resistance in Staphylococcus aureus (MRSA)","volume":"6","author":"C Contreras-Martel","year":"2011","journal-title":"ACS Chem Biol"},{"issue":"Suppl A","key":"ref85","first-page":"20A","article-title":"A review of the mechanisms of action and resistance of antimicrobial agents","volume":"6","author":"R Wise","year":"1999","journal-title":"Can Respir J"},{"key":"ref86","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1128\/CMR.00037-09","article-title":"Three decades of beta-lactamase inhibitors","volume":"23","author":"SM Drawz","year":"2010","journal-title":"Clin Microbiol Rev"},{"key":"ref87","first-page":"1136","article-title":"Antibiotic resistant genes","volume":"61","author":"Y Ishii","year":"2013","journal-title":"Rinsho Byori"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0138895","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,22]],"date-time":"2022-05-22T05:14:26Z","timestamp":1653196466000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0138895"}},"subtitle":[],"editor":[{"given":"Mark A","family":"Webber","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2015,9,23]]},"references-count":87,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2015,9,23]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0138895","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,9,23]]}}}